Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease

Abstract

Continuous treatment with lamivudine delays clinical progression in patients with chronic hepatitis B and advanced fibrosis or cirrhosis by significantly reducing the incidence of hepatic decompensation and the risk of hepatocellular carcinoma.